Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
1d
News Medical on MSNSome gut bacteria could make certain drugs less effectiveA new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...
1d
News-Medical.Net on MSNNew structural and mechanistic understanding for cancer drug designA University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and protects replicating DNA in dividing cells. This new structural and ...
4d
GlobalData on MSNGoogle-backed Isomorphic Labs raises $600m to advance AI drug discoveryThe funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
The event, held in the emblematic Casa de Convalescència, was supported by the BBVA Foundation and welcomed 150 international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results